Health
Three common medications lower risk and mortality for lung cancer – Medical Xpress
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
All three medications are commonapproximately 35 million people take a statin to control cholesterol; more than 120 million people take metformin to control diabetes; and between 6 and 10 million people take aspirin daily.
The aim of this study was to investigate the associations of aspirin, metformin, and st…
-
Noosa News24 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
General18 hours agoIran’s currency at record low as tensions run high
-
General24 hours ago307,000 Voices | The Spectator Australia
-
General24 hours agoLive and dead animals seized from Kyneton business after investigation